Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in QURE — uniQure N.V.

CIK 1446194 BALA CYNWYD, PA
Back to QURE Full portfolio

Position in QURE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$22,887,075
+$6,491,295 QoQ
Shares Held
496,897
-50.4% QoQ
Ownership
0.788%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#36
of 255 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in QURE Over Time

Shares Held

Position Value (USD)

Derivatives in QURE

reported options exposure · as of Jun 30, 2026
CallValue
$118,728,862
CallShares
2,577,700
PutValue
$19,349,806
PutShares
420,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. QURE ranks #20 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in QURE

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,349,806 420,100
2026-06-30 $118,728,862 2,577,700
2026-06-30 $22,887,075 496,897
2026-03-31 $34,006,365 2,079,900
2026-03-31 $16,395,780 1,002,800
2026-03-31 $9,180,525 561,500
2025-12-31 $53,876,002 2,251,400
2025-12-31 $11,936,284 498,800
2025-12-31 $29,155,115 1,218,350
2025-09-30 $13,164,769 225,540
2025-09-30 $53,023,308 908,400
2025-09-30 $51,599,080 884,000
2025-06-30 $16,758,668 1,202,200
2025-06-30 $7,559,662 542,300
2025-06-30 $673,065 48,283
2025-03-31 $1,661,020 156,700
2025-03-31 $3,943,200 372,000
2025-03-31 $438,278 41,347
2024-12-31 $8,597,046 486,809
2024-12-31 $6,776,142 383,700
2024-12-31 $4,478,576 253,600
2024-09-30 $2,335,341 473,700
2024-09-30 $789,263 160,094
2024-09-30 $1,765,926 358,200
2024-06-30 $1,708,672 381,400
2024-06-30 $1,055,488 235,600
2024-06-30 $1,128,821 251,969
2024-03-31 $2,689,960 517,300
2024-03-31 $2,502,760 481,300
2024-03-31 $2,620,191 503,883
2023-12-31 $1,142,261 168,724
2023-12-31 $1,100,802 162,600
2023-12-31 $477,285 70,500
2023-09-30 $1,826,462 272,200
2023-09-30 $787,083 117,300
2023-09-30 $1,627,543 242,555
2023-06-30 $3,062,112 267,200
2023-06-30 $2,356,198 205,602
2023-06-30 $5,308,272 463,200
2023-03-31 $710,942 35,300
2023-03-31 $2,034,140 101,000
2023-03-31 $2,295,476 113,976
2022-12-31 $5,457,099 240,719
2022-12-31 $6,098,230 269,000
2022-12-31 $1,357,933 59,900
2022-09-30 $5,003,292 266,700
2022-09-30 $2,074,856 110,600
2022-09-30 $4,651,542 247,950
2022-06-30 $5,375,794 288,401
2022-06-30 $4,111,984 220,600